Artificial blood vessel

Artificial blood vessel Comprehensive Study by Application (Aortic Disease, Peripheral Artery Disease, Hemodialysis), Material Used (Natural Materials, Synthetic Polymers) Players and Region - Global Market Outlook to 2028

Artificial blood vessel Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Artificial vessels were earlier made by using tubes of glass and aluminum in that period, now the artificial vessels are made from synthetic polymers. Initially, when using donor vessels, arteriosclerosis occurred, and in other cases, donor arteries were rejected by the patient. This leads may lead to clotting, increased visits to the hospital, and risk of infection. More flexible and acceptable synthetic materials were then used as a focus on development. Artificial blood vessels are tubes made from synthetic (chemically produced) materials to restore blood circulation.This growth is primarily driven by Increasing Cases of Cardiovascular Disease .

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Health Care Technology sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Humacyte Inc. (United States), W. L. Gore & Associates (United States), B. Braun Melsungen AG (Germany), Jotec GmbH (Germany), LeMaitre Vascular (United States), Perouse Medical (France) and Nicast (Israel), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In April 2023, Humacyte published a preclinical study in the Journal of Trauma and Acute Care Surgery comparing the use of its Human Acellular Vessel (HAV) to expanded polytetrafluorethylene (ePTFE) grafts for vascular repair following arterial trauma. This strengthened the company’s position in artificial blood vessel market
In August 2021, Fresenius Medical Care one of the products and services for individuals with renal diseases provider additionally invested USD 25 million in the U.S. medical company Humacyte, Inc. Humacyte developed implantable human acellular vessels for multiple vascular repair, reconstruction and replacement. This additional investment helped Humacyte to expand its presence in artificial blood vessel marketThe manufacturers are investing in research and development of effective and long-acting products with minor adverse effects. The players are exploring new geographies through expansions and acquisitions to avail competitive advantage through combined synergies to increase their market share.

Influencing Trend:
Technology Development in Artificial Blood Vessel

Market Growth Drivers:
Increasing Cases of Cardiovascular Disease and Rising Expenditure on Healthcare

Challenges:
The Artificial Materials Used So Far Are Not Fully Compatible With Body Tissue and the Blood Vessel Can Easily Become Blocked

Restraints:
High Cost Related to Artificial Blood Vessel

Opportunities:
Growing Infrastructural Development in Developing Countries

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Artificial blood vessel Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Artificial blood vessel Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Artificial blood vessel players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Artificial blood vessel Study Sheds Light on
— The Artificial blood vessel Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Artificial blood vessel industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Artificial blood vessel industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Application
  • Aortic Disease
  • Peripheral Artery Disease
  • Hemodialysis
By Material Used
  • Natural Materials
  • Synthetic Polymers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Cases of Cardiovascular Disease
      • 3.2.2. Rising Expenditure on Healthcare
    • 3.3. Market Challenges
      • 3.3.1. The Artificial Materials Used So Far Are Not Fully Compatible With Body Tissue and the Blood Vessel Can Easily Become Blocked
    • 3.4. Market Trends
      • 3.4.1. Technology Development in Artificial Blood Vessel
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Artificial blood vessel, by Application, Material Used and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Artificial blood vessel (Value)
      • 5.2.1. Global Artificial blood vessel by: Application (Value)
        • 5.2.1.1. Aortic Disease
        • 5.2.1.2. Peripheral Artery Disease
        • 5.2.1.3. Hemodialysis
      • 5.2.2. Global Artificial blood vessel by: Material Used (Value)
        • 5.2.2.1. Natural Materials
        • 5.2.2.2. Synthetic Polymers
      • 5.2.3. Global Artificial blood vessel Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Artificial blood vessel (Price)
  • 6. Artificial blood vessel: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Humacyte Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. W. L. Gore & Associates (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. B. Braun Melsungen AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Jotec GmbH (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. LeMaitre Vascular (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Perouse Medical (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Nicast (Israel)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Artificial blood vessel Sale, by Application, Material Used and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Artificial blood vessel (Value)
      • 7.2.1. Global Artificial blood vessel by: Application (Value)
        • 7.2.1.1. Aortic Disease
        • 7.2.1.2. Peripheral Artery Disease
        • 7.2.1.3. Hemodialysis
      • 7.2.2. Global Artificial blood vessel by: Material Used (Value)
        • 7.2.2.1. Natural Materials
        • 7.2.2.2. Synthetic Polymers
      • 7.2.3. Global Artificial blood vessel Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Artificial blood vessel (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Artificial blood vessel: by Application(USD Million)
  • Table 2. Artificial blood vessel Aortic Disease , by Region USD Million (2017-2022)
  • Table 3. Artificial blood vessel Peripheral Artery Disease , by Region USD Million (2017-2022)
  • Table 4. Artificial blood vessel Hemodialysis , by Region USD Million (2017-2022)
  • Table 5. Artificial blood vessel: by Material Used(USD Million)
  • Table 6. Artificial blood vessel Natural Materials , by Region USD Million (2017-2022)
  • Table 7. Artificial blood vessel Synthetic Polymers , by Region USD Million (2017-2022)
  • Table 8. South America Artificial blood vessel, by Country USD Million (2017-2022)
  • Table 9. South America Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 10. South America Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 11. Brazil Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 12. Brazil Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 13. Argentina Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 14. Argentina Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 15. Rest of South America Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 16. Rest of South America Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 17. Asia Pacific Artificial blood vessel, by Country USD Million (2017-2022)
  • Table 18. Asia Pacific Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 19. Asia Pacific Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 20. China Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 21. China Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 22. Japan Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 23. Japan Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 24. India Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 25. India Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 26. South Korea Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 27. South Korea Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 28. Taiwan Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 29. Taiwan Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 30. Australia Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 31. Australia Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 32. Rest of Asia-Pacific Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 33. Rest of Asia-Pacific Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 34. Europe Artificial blood vessel, by Country USD Million (2017-2022)
  • Table 35. Europe Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 36. Europe Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 37. Germany Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 38. Germany Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 39. France Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 40. France Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 41. Italy Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 42. Italy Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 43. United Kingdom Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 44. United Kingdom Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 45. Netherlands Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 46. Netherlands Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 47. Rest of Europe Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 48. Rest of Europe Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 49. MEA Artificial blood vessel, by Country USD Million (2017-2022)
  • Table 50. MEA Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 51. MEA Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 52. Middle East Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 53. Middle East Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 54. Africa Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 55. Africa Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 56. North America Artificial blood vessel, by Country USD Million (2017-2022)
  • Table 57. North America Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 58. North America Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 59. United States Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 60. United States Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 61. Canada Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 62. Canada Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 63. Mexico Artificial blood vessel, by Application USD Million (2017-2022)
  • Table 64. Mexico Artificial blood vessel, by Material Used USD Million (2017-2022)
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Artificial blood vessel: by Application(USD Million)
  • Table 73. Artificial blood vessel Aortic Disease , by Region USD Million (2023-2028)
  • Table 74. Artificial blood vessel Peripheral Artery Disease , by Region USD Million (2023-2028)
  • Table 75. Artificial blood vessel Hemodialysis , by Region USD Million (2023-2028)
  • Table 76. Artificial blood vessel: by Material Used(USD Million)
  • Table 77. Artificial blood vessel Natural Materials , by Region USD Million (2023-2028)
  • Table 78. Artificial blood vessel Synthetic Polymers , by Region USD Million (2023-2028)
  • Table 79. South America Artificial blood vessel, by Country USD Million (2023-2028)
  • Table 80. South America Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 81. South America Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 82. Brazil Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 83. Brazil Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 84. Argentina Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 85. Argentina Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 86. Rest of South America Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 87. Rest of South America Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 88. Asia Pacific Artificial blood vessel, by Country USD Million (2023-2028)
  • Table 89. Asia Pacific Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 90. Asia Pacific Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 91. China Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 92. China Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 93. Japan Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 94. Japan Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 95. India Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 96. India Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 97. South Korea Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 98. South Korea Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 99. Taiwan Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 100. Taiwan Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 101. Australia Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 102. Australia Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 103. Rest of Asia-Pacific Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 104. Rest of Asia-Pacific Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 105. Europe Artificial blood vessel, by Country USD Million (2023-2028)
  • Table 106. Europe Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 107. Europe Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 108. Germany Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 109. Germany Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 110. France Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 111. France Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 112. Italy Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 113. Italy Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 114. United Kingdom Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 115. United Kingdom Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 116. Netherlands Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 117. Netherlands Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 118. Rest of Europe Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 119. Rest of Europe Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 120. MEA Artificial blood vessel, by Country USD Million (2023-2028)
  • Table 121. MEA Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 122. MEA Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 123. Middle East Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 124. Middle East Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 125. Africa Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 126. Africa Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 127. North America Artificial blood vessel, by Country USD Million (2023-2028)
  • Table 128. North America Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 129. North America Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 130. United States Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 131. United States Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 132. Canada Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 133. Canada Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 134. Mexico Artificial blood vessel, by Application USD Million (2023-2028)
  • Table 135. Mexico Artificial blood vessel, by Material Used USD Million (2023-2028)
  • Table 136. Research Programs/Design for This Report
  • Table 137. Key Data Information from Secondary Sources
  • Table 138. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Artificial blood vessel: by Application USD Million (2017-2022)
  • Figure 5. Global Artificial blood vessel: by Material Used USD Million (2017-2022)
  • Figure 6. South America Artificial blood vessel Share (%), by Country
  • Figure 7. Asia Pacific Artificial blood vessel Share (%), by Country
  • Figure 8. Europe Artificial blood vessel Share (%), by Country
  • Figure 9. MEA Artificial blood vessel Share (%), by Country
  • Figure 10. North America Artificial blood vessel Share (%), by Country
  • Figure 11. Global Artificial blood vessel share by Players 2022 (%)
  • Figure 12. Global Artificial blood vessel share by Players (Top 3) 2022(%)
  • Figure 13. BCG Matrix for key Companies
  • Figure 14. Humacyte Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 15. Humacyte Inc. (United States) Revenue: by Geography 2022
  • Figure 16. W. L. Gore & Associates (United States) Revenue, Net Income and Gross profit
  • Figure 17. W. L. Gore & Associates (United States) Revenue: by Geography 2022
  • Figure 18. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 19. B. Braun Melsungen AG (Germany) Revenue: by Geography 2022
  • Figure 20. Jotec GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Jotec GmbH (Germany) Revenue: by Geography 2022
  • Figure 22. LeMaitre Vascular (United States) Revenue, Net Income and Gross profit
  • Figure 23. LeMaitre Vascular (United States) Revenue: by Geography 2022
  • Figure 24. Perouse Medical (France) Revenue, Net Income and Gross profit
  • Figure 25. Perouse Medical (France) Revenue: by Geography 2022
  • Figure 26. Nicast (Israel) Revenue, Net Income and Gross profit
  • Figure 27. Nicast (Israel) Revenue: by Geography 2022
  • Figure 28. Global Artificial blood vessel: by Application USD Million (2023-2028)
  • Figure 29. Global Artificial blood vessel: by Material Used USD Million (2023-2028)
  • Figure 30. South America Artificial blood vessel Share (%), by Country
  • Figure 31. Asia Pacific Artificial blood vessel Share (%), by Country
  • Figure 32. Europe Artificial blood vessel Share (%), by Country
  • Figure 33. MEA Artificial blood vessel Share (%), by Country
  • Figure 34. North America Artificial blood vessel Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Humacyte Inc. (United States)
  • W. L. Gore & Associates (United States)
  • B. Braun Melsungen AG (Germany)
  • Jotec GmbH (Germany)
  • LeMaitre Vascular (United States)
  • Perouse Medical (France)
  • Nicast (Israel)
Select User Access Type

Key Highlights of Report


May 2023 201 Pages 65 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Artificial blood vessel Quantitative research analysis
Artificial blood vessel Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2023 to 2028
Companies that are profiled in Global Artificial blood vessel Market are Humacyte Inc. (United States), W. L. Gore & Associates (United States), B. Braun Melsungen AG (Germany), Jotec GmbH (Germany), LeMaitre Vascular (United States), Perouse Medical (France) and Nicast (Israel) etc.
Aortic Disease segment in Global market to hold robust market share owing to "Increasing Cases of Cardiovascular Disease ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Artificial blood vessel market throughout the forecasted period.

Know More About Artificial blood vessel Report?

Have a Query? Click Here

Other Related Reports

Tumor Ablation Comprehensive Study by Application (Liver Cancer, Lung Cancer, Breast Cancer, Prostate Cancer, Others), Treatment (Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation), Tec...
$ 3650
Breakthrough Therapy Comprehensive Study by Application (Oncology, Infectious Diseases, Rare Diseases, Autoimmune Diseases, Pulmonary Diseases, Neurological Disorders, Others), End-users (Hospitals, ...
$ 3450
Medical Document Management Systems Comprehensive Study by Type (Solution, Service), Application (Patient Medical Records Management, Image Management, Admission and Registration Documents Management...
$ 3750
Medical Holography Comprehensive Study by Type (Holographic Display, Microscope, Print, Software), Application (Medical Imaging, Medical Education, Biomedical Research), Holographic Display (Laser, T...
$ 3750
Medical Simulation Comprehensive Study by Type (Intelligent System, Fully Automatic, Semi-Automatic, Manual Control, Other), Application (Medical Colleges, Hospitals, Medical Training Institutions, O...
$ 3650
Flat Panel Detector Comprehensive Study by Type (Portable Flat Panel Detector, Wireless Flat Panel Detector), Application (Hospital & Clinic, Scientific Research, Other), Size Type (Small-Area Flat-P...
$ 3450